Rare Neurodegenerative Disease Treatment Market
Rare Neurodegenerative Disease Treatment Market Study by Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Acute Migraine, Autism, Narcolepsy, ALS, ADHD, and Others from 2023 to 2033
Analysis of Rare Neurodegenerative Disease Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Author:
Md Sanaullah
Editor:
Anushree Karale
- FACT5197MR
- 10 Feb 2023
- Healthcare
- 170 Pages
- 30 Tables
- 78 Figures
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background and Associated Industry Indicators
- 4. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 5. Global Market - Pricing Analysis
- 6. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
- 7.1 Multiple Sclerosis
- 7.2 Alzheimer’s Disease
- 7.3 Parkinson Disease
- 7.4 Acute Migraine
- 7.5 Autism
- 7.6 Narcolepsy
- 7.7 Amyotrophic Lateral Sclerosis (ALS)
- 7.8 Attention Deficit Hyperactivity Disorder (ADHD)
- 7.9 Spinal Muscular Atrophy
- 7.10 Tourette Syndrome
- 7.11 Huntington’s Disease
- 7.12 Others
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
- 8.1 Neurotransmitter Agents
- 8.2 Neuroprotective Agents
- 8.3 Biologics
- 8.4 Others
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
- 9.1 Hospital Pharmacies
- 9.2 Online Pharmacies
- 9.3 Retail Pharmacies
- 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 10.1 North America
- 10.2 Europe
- 10.3 Asia Pacific
- 10.4 Latin America
- 10.5 Middle East & Africa
- 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1 Allergan Plc
- 18.2 Bayer AG
- 18.3 F. Hoffmann-La Roche Ltd.
- 18.4 GlaxoSmithKline Plc
- 18.5 Johnson & Johnson
- 18.6 Merck KGaA
- 18.7 Novartis AG
- 18.8 Pfizer Inc.
- 18.9 Sanofi
- 18.10 Teva Pharmaceuticals Industries Ltd.
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 02: Global Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 04: Global Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 05: Global are Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2023 to 2033
Table 06: North America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 07: North America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 08: North America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 09: North America Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 10: North America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 11: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 12: Europe Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 13: Europe Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 14: Europe Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 15: Europe Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 17: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 18: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 21: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 22: Latin America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 23: Latin America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 24: Latin America Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 26: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 27: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 28: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 29: Middle East & Africa Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 30: Middle East & Africa Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
List Of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 02: Global Market Value Share, by Indication, 2023
Figure 03: Global Market Value Share, by Drug Class, 2023
Figure 04: Global Market Value Share, by Distribution Channel, 2023
Figure 05: Global Market Value Share, by Region, 2023
Figure 06: Global Market Value Share Analysis, by Indication, 2023 and 2033
Figure 07: Global Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 08: Global Market Value (US$ Mn), by Multiple Sclerosis (MS), 2023 to 2033
Figure 09: Global Market Value (US$ Mn), by Alzheimer’s Disease, 2023 to 2033
Figure 10: Global Market Value (US$ Mn), by Parkinson's Disease, 2023 to 2033
Figure 11: Global Market Value (US$ Mn), by Acute Migraine, 2023 to 2033
Figure 12: Global Market Value (US$ Mn), by Autism, 2023 to 2033
Figure 13: Global Market Value (US$ Mn), by Narcolepsy, 2023 to 2033
Figure 14: Global Market Value (US$ Mn), by Amyotrophic Lateral Sclerosis (ALS), 2023 to 2033
Figure 15: Global Market Value (US$ Mn), by Attention Deficit Hyperactivity Disorder (ADHD), 2023 to 2033
Figure 16: Global Market Value (US$ Mn), by Spinal Muscular Atrophy, 2023 to 2033
Figure 17: Global Market Value (US$ Mn), by Tourette Syndrome, 2023 to 2033
Figure 18: Global Market Value (US$ Mn), by Huntington's disease, 2023 to 2033
Figure 19: Global Market Value (US$ Mn), by Others, 2023 to 2033
Figure 20: Global Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 21: Global Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 22: Global Market Value (US$ Mn), by Neuroprotective Agents, 2023 to 2033
Figure 23: Global Market Value (US$ Mn), by Neurotransmitter Agents, 2023 to 2033
Figure 24: Global Market Value (US$ Mn), by Biologics, 2023 to 2033
Figure 25: Global Market Value (US$ Mn), by Others, 2023 to 2033
Figure 26: Global Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 27: Global Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 28: Global Market Value (US$ Mn), by Hospital Pharmacies, 2023 to 2033
Figure 29: Global Market Value (US$ Mn), by Online Pharmacies, 2023 to 2033
Figure 30: Global Market Value (US$ Mn), by Retail Pharmacies, 2023 to 2033
Figure 31: Global Market Value Share Analysis, by Region, 2023 and 2033
Figure 32: Global Market Attractiveness Analysis, by Region, 2023 to 2033
Figure 33: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis, by Country, 2023 and 2033
Figure 35: North America Market Value Share Analysis, by Country, 2023 to 2033
Figure 36: North America Market Value Share Analysis, by Indication, 2023 and 2033
Figure 37: North America Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 38: North America Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 39: North America Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 40: North America Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 41: North America Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 42: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 43: Europe Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 44: Europe Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 45: Europe Market Value Share Analysis, by Indication, 2023 and 2033
Figure 46: Europe Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 47: Europe Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 48: Europe Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 49: Europe Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 50: Europe Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 51: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 52: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 53: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 54: Asia Pacific Market Value Share Analysis, by Indication, 2023 and 2033
Figure 55: Asia Pacific Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 56: Asia Pacific Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 57: Asia Pacific Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 58: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 59: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 60: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 61: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 62: Latin America Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 63: Latin America Market Value Share Analysis, by Indication, 2023 and 2033
Figure 64: Latin America Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 65: Latin America Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 66: Latin America Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 67: Latin America Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 68: Latin America Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 69: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 70: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 71: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 72: Middle East & Africa Market Value Share Analysis, by Indication, 2023 and 2033
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 74: Middle East & Africa Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 75: Middle East & Africa Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 76: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 77: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 78: Global Market Share Analysis, by Company, 2023
Rare Neurodegenerative Disease Treatment Market